Current location of surgical treatment in ovarian cancer;AKTUELLE STANDORTBESTIMMUNG ZUR OPERATIVEN THERAPIE DES OVARIALKARZINOMS

Zentralblatt fur Gynakologie

Volumn 120, Issue 1, 1998, Pages 3-16

  Faridi, A ^a   Schroder W ^a   Rath, W ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Interval cytoreduction; Ovarian carcinoma; Primary and secondary cytoreduction; Systemic lymphonodectomy; Tumor biology

Indexed keywords

CISPLATIN;

AGE; CANCER STAGING; CHEMOTHERAPY; DOPPLER ECHOGRAPHY; FEMALE; FERTILITY; HUMAN; INTESTINE OBSTRUCTION; LAPAROSCOPY; LAPAROTOMY; LYMPHADENECTOMY; MORTALITY; OVARY CANCER; PALLIATIVE THERAPY; PAPANICOLAOU TEST; PROGNOSIS; QUALITY OF LIFE; RELAPSE; REVIEW; SECOND LOOK SURGERY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; OVARIECTOMY; POSTOPERATIVE CARE; PREOPERATIVE CARE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0031983534     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Allen DG, Heintz AP, Touw FW: A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Eur J Gynaecol Oncol 16 (1995) 349-356
2. Barber HRK: Ovarian Carcinoma. Etiology, Diagnosis and Treatment. 3. Aufl., Berlin: Springer 1993
3. Berek J: Interval debulking of ovarian cancer - an interim measure. N Engl J Med 332 (1995) 675-677
4. Bertelsen K: Tumor Reduction Surgery and Long-Term Survival in advanced ovarian cancer: A DACOVA Study. Gynecol Oncol 38 (1990) 203-209
5. Bolis G, Villa A, Guarnerio P, Ferraris C, Gavoni N, Giardina G, MelpignaNO M, Scarfone G, Zanaboni F, Parazzini F. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparatomy. Cancer 77 (1996) 128-131
6. Burghardt E, Pickel H, Lahousen H, Stettner H: Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 155 (1986) 315-319
7. Burghardt E, Lahousen M, Stettner H: Die operative Behandlung des Ovarialkarzinoms. Geburtshilfe Frauenheilkd 50 (1990) 670-677
8. Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H: Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40 (1991) 103-106
9. Clark-Pearson DL, Kohler MF, Hurteau JA, Elbendary A: Surgery of advanced ovarian cancer. Clin Obstet Gynecol 37 (1994) 439-460
10. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C: Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 55 (1994) Suppl., 47-51
11. Creasman WT: Second-look laparotomy in ovarian cancer. Gynecol Oncol 55 (1994) Suppl., 122-127
12. Elchalal U, Dgani R, Piura B, Anteby SO, Zalel Y, Czemobilsky B, Schenker JG: Current concepts in management of epithelial ovarian tumors of low malignant potential. Obstet Gynecol Surv 50 (1994) 62-70
13. Farias-Eisner R, Teng F, Oliveira M, Leuchter R, Karlan B, Lagasse LD, Berek JS: The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery. Gynecol Oncol 55 (1994) Suppl., 108-10
14. Faridi A, Beck L: Die Appendektomie als Zusatzeingriff bei einer gynäkologischen Laparotomie. In: Intra- und postoperative Komplikationen in der Gynäkologie und Geburtshilfe. Hrsg.: Beck L, Bender HG. Stuttgart: Thieme 2. Aufl. 1996, 123-126
15. Gershenson DM: Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 55 (1994) Suppl., 62-72
16. Griffiths CT: Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Caner Inst Monogr 42 (1975) 101-104
17. Hacker NF: Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer-therapeutic advance or surgical folly ? Gynecol Oncol 56 (1995) 325-327
18. Hoskins WJ, Rubin SC, Dulaney E, Chapman D, Almodrones L, Saigo P, Markmann M, Hakes T, Reichmann B, Jones WB, Lewis JL: Influence of secondary cytoreduktion at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 34 (1989) 365-371
19. Hoskins WJ, Bundy BN, Thigpen JT, Omura GA: The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol 47 (1992) 159-166
20. Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, Ball H, Berek JS: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epthelial ovarian carcinoma. Am J Obstet Gynecol 170 (1994) 974-980
21. Hoskins WJ: Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol. 55 (1994) Suppl., 91-96
22. Hunter RW, MBBS, Alexander NDE, DipMathStat, Soutter WP: Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis ? Am J Obstet Gynecol 166 (1992) 504-511
23. Jänicke F, Hölscher M, Kuhn W, von Hugo R, Pache L, Siewert JR, Graeff H: Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 70 (1992) 2129-2136
24. Jänicke F: Die Rolle der Lymphonodektomie bei der organerhaltenden Therapie des Ovarialkarcinoms. Zentralbl Gynakol 118 (1996) 331-332
25. Kehoe S, Shafi M, Luesley D: Interval cytoreduction in ovarian cancer. N Engl J Med 333 (1995) 254
26. Kehoe S: Primary debulking surgery in advanced ovarian carcinoma. Br J Obstet Gynaecol 103 (1996) 291-293
27. Kindermann G, Maaßen V, Kuhn W: Laparoskopisches Anoperieren von ovariellen Malignomen. Geburtshilfe Frauenheilkd 55 (1995) 687-694
28. Kleine W: Ergebnisse fertilitätserhaltender Operationen bei malignen Ovarialtumoren. Zentralbl Gynakol 118 (1996) 317-321
29. Kuhn W, Jänicke F, Pache L, Hölscher M, Schattenmann G, Schmalfeldt B, Anderl H, Schüle G, Dettmar P, Siewert JR, Graeff H: Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO III. Geburtshilfe Frauenheilkd 53 (1993) 293-302
30. Makar AP, Baekelandt M, Trope CG, Kristensen GB: The prognostic significance of residual disease. FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 56 (1995) 175-180
31. Meerpohl HG, Sauerbrei W, Schumacher M, Pfleiderer A: Welche Parameter beeinflussen die Größe des postoperativen Tumorrestes beim Ovarialkarzinom?
32. Meier W, Römisch M, Hepp H: Stellenwert der tumorreduktiven Sekundäroperation (Interventionslaparotomie) beim Ovarialkarzinom. Geburtshilfe Frauenheilkd 53 (1993) 860-865
33. Neijet JP: Treatment of advanced ovarian cancer: 10 years of experience. Ann Oncol 3 (1992) 17-27
34. Nicklin JL, Copeland LJ, O'Toole RV, Lewandowski GS, Vaccarello L, Havenar LP: Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol. 58 (1995) 244-247
35. National Institutes of Health (NIH) Consensus Development Conference Statement: Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol 55 (1994) Suppl., 128-133
36. Paterok EM, Siebzehnrübl E, Meyer M: Altersspezifische und alterskorrigierte Mortalität gynäkologischer Karzinome - einschl. Mamma-Karzinom. Geburtshilfe Frauenheilkd 55 (1995) 177-181
37. Pecorelli S, Sartori E, Santin A:. Follow-up after primary therapy: management of the symptomatic patient-surgery. Gynecol Oncol 55 (1994) Suppl., 138-142
38. Petru E, Lahousen M, Tamussino K, Pickel H, Stranzl H, Stettner H, Winter R: Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170 (1995) 656-662
39. Pfleiderer A: Die operative Therapie des Ovarialkarzinoms. Arch Gynec 242 (1987) 26-39
40. Pfleiderer A: Malignome des Ovars. In: Klinik der Frauenheilkunde und Geburtshilfe Bd 12. Hrsg.: Wulf KH, Schmidt-Matthiesen H, München: Urban & Schwarzenberg 3. Aufl. 1996, 1-109
41. Podratz KC, Cliby WA: Second-look surgery in the management of epithelial ovarian carcinoma. Gynecol Oncol 55 (1994) Suppl., 128-133
42. Rath W, Meden H, Brill U, Grospietsch G, Kuhn W: Surgical treatment of ovarian cancer at the Department of Obstetrics and Gynecology University of Göttingen, Germany. In: Das Ovarialkarzinom. 2 Therapie. Hrsg.: Meerpohl HG, Pfleiderer A, Profous CZ. Berlin: Springer 1993, 19-23
43. Rath W: Laparoskopie oder Laparotomie bei Ovarialtumoren - eine nicht endende Kontroverse. Frauenarzt 37 (1996) 1472-1482
44. Salzer H, Sevelda P, Genger H, Schmidl S, Denison U, Barrada M, Vavra N, Kucera H: Die Bedeutung der Staging-Operation bei den Frühstadien des Ovarialkarzinoms. Wien Klin Wochenschr 102 (1990) 437-440
45. Schröder W.: Adjuvante Therapie bösartiger Ovarialtumoren nach Organerhalt. Zentralbl Gynakol 118 (1996) 565-570
46. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E: Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 56 (1995) 328-337
47. Sevin BU: Operative Behandlung der Karzinome der Ovarian und der Tuben. In: Kirschnersche allgemeine und spezielle Operationslehre. Gynäkologische Operationen. Hrsg.: Zander J, Graeff H. Berlin: Springer 1991
48. Soper JT: Management of early stage epithelial ovarian cancer. Clin Obstet Gynecol 37 (1994) 423-438
49. Speiser P, Salzer H, Vavra K, Czerwenka K, Pateisky N, Dittrich C, Sevelda P: Die zytoreduktive Zweitoperation kann das Überleben von Patientinnen mit partieller Remission nach First line Chemotherapie und fortgeschrittenem epithelialen Ovarialkarzinom verlängern. In: Das Ovarialkarzinom. 2 Therapie. Hrsg.: Meerpohl HG, Pfleiderer A, Profous CZ. Berlin: Springer 1993, 35-41
50. Spirtos NM, Gross GM, Freddo JL, Ballon SC: Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 56 (1995) 345-352
51. Spirtos NM, Schlaerth JB, Spirtos TW, Schlaerth AC, Indman PD, Kimball RE: Laparoscopic bilateral pelvic and paraaortic lymph node sampling: an evolving technique. Am J Obstet Gynecol 173 (1995) 105-111
52. Teufel G, Aisslinger U, Nicolai M: Rezidivchirurgie bei Ovarialkarzinomen. In: Das Ovarialkarzinom. 2 Therapie. Hrsg.: Meerpohl HG, Pfleiderer A, Profous CZ. Berlin: Springer 1993, 43-53
53. Trimble CL, Trimble EL, MPH: Management of epithelial ovarian tumors of low malignant potential. Gynecol Oncol 55 (1994) Suppl., 52-61
54. Tulusan AH, Di Paolo M, Atanasov N, Bühner M, Rosenthal H, Lang N, Hohenberger W, Altendorf A: Isolierte thorakale Metastasen - Denkanstöße zu einem neuen Therapiekonzept beim fortgeschrittenen Ovarialkarzinom. In: Das Ovarialkarzinom. 2 Therapie. Hrsg.: Meerpohl HG, Pfleiderer A, Profous CZ. Berlin: Springer 1993, 63-67
55. Vaccarello L, Rubin SC, Vlamis V, Wong G, Jones WB, Lewis JL, Hoskins WJ: Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol 57 (1995) 61-65
56. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S: The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 332 (1995) 629-634
57. Winter R, Lahousen M, Pickel H: Indikation und Bedeutung der Lymphadenektomie beim Stadium II und III des Ovarialkarzinoms. In: Das Ovarialkarzinom. 2 Therapie. Hrsg.: Meerpohl HG, Pfleiderer A, Profous CZ. Berlin: Springer 1993, 11-17
58. Wu PS, Qu J, Lang J, Huang R, Tang M, Lian L, Lymph node metastasis of ovarian cancer: preliminary survey of 74 cases of lymphadenectomie. Am J Obstet Gynecol 155 (1986) 1103-1108
59. Young RC, Decker DO, Wharton JT, Piver MS, Sindelav WV, Edwards BK, Smith JP: Staging laparatomy in early ovarian cancer. JAMA 250 (1983) 3072-3076